ADHD Study for Children – Stimulant
Jornay vs Placebo
$85 per completed visit
Study Specific Details:
- Jornay vs Placebo – this is a a randomized, double-blind, parallel-group, placebo-controlled study. Dr. Handal will be able to find out medication the subject is on in case of emergency.
- Entire study is about 2 months (6 total visits) with 4 weekly visits and an end of study visit.
- Participants are reimbursed $85 for their time and travel at the end of each completed visit.
- Inclusion
- Exclusion
- Male or Female ages 4-5.
- Must meet DSM-5 criteria for a primary diagnosis of ADHD based on a psychiatric evaluation using the MINI-KID.
- Height and weight must be between the 5th and 95th percentile for age and gender.
- Must have undergone an adequate course of nonpharmacologic treatment or has a severe enough condition in the opinion of the investigator to consider enrollment prior to nonpharmacologic treatment.
- Initiation of Cognitive Behavioral Therapy within 30 days prior to baseline.
- Oppositional defiant disorder (ODD) is allowed as long as it is not the primary focus of treatment.
- Mood disorder is at the discretion of the PI.
- Any diagnosis of psychosis, bipolar, major depressive disorder, anxiety disorder, eating disorder, conduct disorder, or OCD
- History of psychosis, autism, tic disorder, disruptive mood dysregulation disorder, intellectual disability, Tourette's Syndrome, confirmed genetic disorder with cognitive and/or behavioral disturbances.
- History of seizure disorder (except febrile seizures prior to age 4 and with the last occurrence at least 1 year prior to study participation).
- Patient is considered to be at risk of suicide.
Questions? Give Us A Call!
Contact Us
Want to learn more about Harmonex Neuroscience Research?